FDA Inspection 1237456 — Emma Ciafaloni, M.D.
The FDA completed an inspection of Emma Ciafaloni, M.D. on Mar 8, 2024 in Rochester, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 8, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Rochester, NY (United States)
Additional Details
Clinical Investigator (CI)